# Eric Eskioğlu

A neurosurgeon who writes about healthcare, including AI adoption, hospital leadership, and the role of pharmacy in clinical care.

- Profile: https://b2binfluencer.marketing/creators/eric-eskio-lu/
- LinkedIn: https://www.linkedin.com/in/eric-eskioglu
- LinkedIn followers: 15,192
- Topics: artificial-intelligence, healthcare
- Based on 12 dated posts, latest 2026-09-29

## Summary

Eric Eskioğlu is most useful for a clinician's perspective on healthcare AI adoption, hospital leadership, and health system finances.

- Best for: A healthcare AI company wanting co-authored or commissioned thought-leadership on clinical adoption.
- Not for: A consumer telehealth or DTC wellness brand wanting paid, high-reach sponsored campaigns with patient testimonials.
- Check first: Confirm paid collaboration terms, deliverables, and audience composition before committing.

### Takeaways

- Pharmacy deserves a hospital C-suite seat, not only a bedside role.
- AI adds clinical help; the open question is how medicine's gatekeepers react.
- Cost and efficiency are the constraints shaping everything else in healthcare.

## Main ideas

- **Pharmacy deserves a seat in the hospital C-suite, not only a role at the bedside**: Eskioğlu argues that large health systems staff chief medical, nursing, financial, legal, consumer, and technology officers but almost never a chief pharmacy officer, even though pharmacy carries a large share of clinical delivery and roughly 15–20% of a system's revenue. The reasoning is about representation rather than capability: "Respect and inclusivity should start at the top." Writing as a neurosurgeon who works closely with pharmacists, Eskioğlu sides with pharmacy colleagues in their dispute with the AMA and describes primary care physicians as already burned out by "overwhelming amounts of data and patient demands," concluding that "medicine is a team sport" and welcoming help that reduces cognitive overload.
- **AI adds clinical help; the open question is how medicine's gatekeepers will react**: Eskioğlu treats AI as another source of help for overloaded clinicians, not a replacement. They predict AI will sit "at the forefront" of efforts to make care cheaper and more efficient, and compare its expansion to an existing professional turf fight: will the AMA object to "AI-scope creep" as it does to pharmacists taking on more clinical work? The argument is less about model accuracy than about who takes on new tasks—and who objects.
- **Cost and efficiency are the constraints shaping everything else in healthcare**: Eskioğlu reads policy and finance news through margin arithmetic. They point to healthcare at roughly 30% of US GDP, waste estimated by some at above 50%, and academic medical centers facing a shift in research indirect overhead rates from 50–70% to a flat 15%. They expect significant cuts, disruption, and scrutiny of what care actually costs.
- **Raises political forces in healthcare, then asks readers to leave politics out of the discussion**: Eskioğlu names politically charged figures—Elon Musk and Vivek Ramaswamy at the Department of Government Efficiency and Robert F. Kennedy Jr. as a possible HHS secretary—as forces shaping healthcare decisions. They then separate operational questions from politics, asking commenters for healthcare opinions rather than political debate, and sign off with "Ad Astra Per Aspera!"

## Work to read

- [Why there is no chief pharmacy officer in the hospital C-suite](https://www.linkedin.com/posts/eric-eskioglu_pharmacists-confront-amas-scope-creep-activity-7169557530212315136-Pq9e)
- [Three post-election predictions for healthcare and AI](https://www.linkedin.com/posts/eric-eskioglu_after-the-elections-whats-next-for-healthcare-activity-7264282644991897600-BbnK)
- [Academic medical centers and the research overhead question](https://www.linkedin.com/posts/eric-eskioglu_i-wonder-if-mgb-health-system-is-a-canary-activity-7295179088711839746-qEdk)

## Brand relationships

- **American Medical Association** (mention)

## Partnerships

The three posts by Eric Eskioğlu — on pharmacy leadership in health-system C-suites (March 2024), academic medical center research overhead rates (February 2025), and healthcare AI policy after the 2024 US election (November 2024) — contain no sponsorship disclosures, branded-content labels, rate cards, or stated offer formats. They do not specify partnership deliverables, pricing, or who handles inquiries. Ask directly through LinkedIn whether paid collaborations are offered, what deliverables and disclosure language they use, and what turnaround is typical.

## Alternatives

- Buhir Rafiq: Choose Rafiq over Eskioğlu for the same healthcare AI campaign only when the vendor's route into the account runs through pharmacy owners and their finance function, not hospital executives. Rafiq's posts frame the buying decision as a finance-staffing question: whether a pharmacy keeps bookkeeping in house, outsources to a specialist pharmacy accountant or takes a hybrid approach, and who handles NHS statement reconciliation, VAT treatment, HMRC compliance, management accounts and tax planning. A vendor selling financial software, virtual CFO services or back-office automation to UK pharmacy businesses would get a more direct message from Rafiq than from Eskioğlu, whose published arguments address hospital C-suite representation and system-level cost pressure rather than pharmacy-owner operations.
- Sana Dalvi: Choose Dalvi over Eskioğlu when the AI product is deployed at unit level and the campaign needs to show what readiness and adoption look like on the floor. The two posts are detailed first-person accounts of EHR implementation site visits: device-to-user ratios that become visible only at peak times; equipment listed as available but unusable; workarounds such as extension cords used as permanent power and paper processes filling system gaps; Wi-Fi dead zones found room by room; and the argument that a readiness model built for inpatient nursing breaks down in pharmacy, medical imaging or allied health. The second post describes multi-initiative fatigue on nursing units and practical responses — a trusted person per shift, same-day availability and one-page reference guides handed out on the floor — as well as the distinction between a unit that absorbed a change and one that survived it with workarounds. For a vendor facing frontline resistance, Dalvi offers concrete, inspectable experience that Eskioğlu does not publish.
- Geoff Vercauteren: Choose Vercauteren when the real subject is healthcare workforce supply rather than AI adoption. The posts describe representing Tufts Medicine and Lowell General Hospital at a life-sciences event and attending a conference hosted by UW Health. They set out a workforce agenda: youth career exploration; partnerships with high schools, community colleges, universities, workforce boards and community organisations; apprenticeships, career pathways and retention; and the position that no single organisation can solve workforce shortages alone. A vendor selling AI documentation, scheduling or training tools to workforce or talent leaders, with a pitch focused on capacity and staffing rather than clinical accuracy, would find a closer starting point here than in Eskioğlu's posts.

---
AI-assisted summary of public posts. Audience demographics are not available. Engagement appears only where we checked recent posts. Method: https://b2binfluencer.marketing/methodology/